Q1 2017 Holdings
Filed 2017-05-15 | 44 holdings | $39.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Axogen Inc(AXGN) | COM | 05463X106 | $20.6M | 1,970,000 | 51.7% |
| Agios Pharmaceuticals(AGIO) | COM | 00847X104 | $7.6M | 130,000 | 19.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $5.9M | 340,000 | 14.7% |
| Codexis Inc(CDXS) | COM | 192005106 | $5.6M | 1,170,000 | 14.1% |
| Blueprint Medicines(2L9) | COM | 09627Y109 | $35.2K | 880,000 | 0.1% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $8.1K | 330,000 | 0.0% |
| Novelion Therapeutics Inc | COM NEW | 67001K202 | $7.8K | 730,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $7.8K | 1,215,000 | 0.0% |
| Cara Therapeutics(CARAEUR) | COM | 140755109 | $7.1K | 385,000 | 0.0% |
| Theravance Biopharma Inc(TBPH) | COM | G8807B106 | $6.6K | 180,000 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $6.2K | 960,000 | 0.0% |
| Momenta Pharmaceuticals Inc(MNTA) | COM | 60877T100 | $5.9K | 440,000 | 0.0% |
| Strongbridge Biopharma PLC | COM | G85347105 | $5.6K | 1,180,000 | 0.0% |
| Loxo Oncology | COM | 548862101 | $5.5K | 130,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $5.1K | 550,000 | 0.0% |
| Adamas Pharmaceuticals Inc(ADMSEUR) | COM | 00548A106 | $5.1K | 290,000 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $4.9K | 87,100 | 0.0% |
| Eagle Pharmaceuticals Inc(EGRX) | COM | 269796108 | $4.1K | 50,000 | 0.0% |
| Imprimis Pharmaceuticals Inc | COM NEW | 45323A201 | $3.6K | 860,500 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $3.2K | 45,000 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $3.2K | 120,000 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $3.1K | 100,000 | 0.0% |
| Sangamo Biosciences Inc(SGMO) | COM | 800677106 | $3.0K | 581,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365AAB7 | $2.6K | 1,930,000 | 0.0% |
| Edge Therapeutics Inc | COM | 279870109 | $2.6K | 280,000 | 0.0% |
| Foamix Pharmaceuticals LTD | SHS | M46135105 | $2.5K | 500,000 | 0.0% |
| Zosano Pharma Corp | COM | 98979H103 | $2.4K | 1,250,000 | 0.0% |
| Sunesis Pharmaceuticals Inc | COM PAR | 867328700 | $2.3K | 550,000 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $2.2K | 78,300 | 0.0% |
| Aevi Genomic Medicine Inc(GNMXEUR) | COM | 00835P105 | $2.0K | 1,070,000 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $2.0K | 50,000 | 0.0% |
| Lion Biotechnologies Inc | COM | 53619R102 | $1.7K | 230,000 | 0.0% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $1.4K | 360,000 | 0.0% |
| Aquinox Pharmaceuticals Inc | COM | 03842B101 | $1.4K | 85,000 | 0.0% |
| Abeona Therapeutics Inc(ABEO1EUR) | COM | 00289Y107 | $1.4K | 275,000 | 0.0% |
| Tonix Pharmaceuticals Holding | COM NEW | 890260201 | $1.1K | 235,000 | 0.0% |
| Cidara Therapeutics Inc | COM | 171757107 | $955 | 122,500 | 0.0% |
| Albireo Pharma Inc(BDQM) | COM | 01345P106 | $876 | 36,500 | 0.0% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $770 | 60,000 | 0.0% |
| Corium International Inc | COM | 21887L107 | $677 | 162,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $593 | 560,000 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $400 | 25,149 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $287 | 40,400 | 0.0% |
| Biolinerx LTD | SPONSORED ADR | 09071M106 | $240 | 250,000 | 0.0% |